Search results
Results from the WOW.Com Content Network
The Dengvaxia controversy (locally [dɛŋˈvakʃa]) occurred in the Philippines when the dengue vaccine Dengvaxia was found to increase the risk of disease severity for some people who had received it. [1] [2] A vaccination program run by the Philippine Department of Health (DOH) administered Sanofi Pasteur's Dengvaxia to schoolchildren. [3]
At EW 19 in Late May, Brazil made up the vast majority of cases of dengue fever reported in Latin America and the Caribbean in 2024, with 83% of suspected cases arising from Brazil, along with 79.4% of deaths. 6,803,727 cases were reported, and 2,897 deaths have been reported.
Mild cases of dengue fever can easily be confused with several common diseases including Influenza, measles, chikungunya, and zika. [61] [62] Dengue, chikungunya and zika share the same mode of transmission (Aedes mosquitoes) and are often endemic in the same regions, so that it is possible to be infected simultaneously by more than one disease ...
The number of cases of dengue fever in Central and South America has nearly tripled to a record high this year, the Pan American Health Organisation (Paho) said on Tuesday. More than 12.6m cases ...
Dengue vaccine is a vaccine used to prevent dengue fever in humans. [9] Development of dengue vaccines began in the 1920s but was hindered by the need to create immunity against all four dengue serotypes. [10] As of 2023, there are two commercially available vaccines, sold under the brand names Dengvaxia and Qdenga. [11] [12]
For premium support please call: 800-290-4726 more ways to reach us
Epidemic dengue has become more common since the 1980s. By the late 1990s, dengue was the most important mosquito-borne disease affecting humans after malaria, with around 40 million cases of dengue fever and several hundred thousand cases of dengue hemorrhagic fever each year. Significant outbreaks of dengue fever tend to occur every five or ...
The 2019–2020 dengue fever epidemic was an epidemic of the infectious disease dengue fever in several countries of Southeast Asia, including the Philippines, Malaysia, Vietnam, and Bangladesh, [1] Pakistan, [2] India, Thailand, Singapore, and Laos. [3]